Hybrid OR

transcatheter mitral valve replacement, Sapien used for Mitral valve

Doctors at Henry Ford Hospital in Detroit used an Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device to repair a mitral va...

Corevalve, FDA, market approval

The U.S. Food and Drug Administration (FDA) granted U.S. market approval for Medtronic’s self-expanding transcatheter aortic valve replacement (TAVR) CoreValve System....

Four cardiovascular professional societies released an overview of transcatheter therapies for mitral regurgitation. Intended to “help frame subsequent discussions” among the field’s various stakeholders, the document highlights critical issues th...

Boston Scientific Corp. has received CE mark for its Lotus Valve System, a transcatheter aortic valve replacement (TAVR) technology. This key approval offers an effective new treatment alternative for patients with severe aorti...

U.S. CoreValve High Risk trial TCT 2014
According to a new study, transcatheter aortic valve replacement (TAVR) provided meaningful clinical benefits relative to surgical aortic valve replacement (...
PARTNER I Trial TCT 2014 TAVR Heart Valve Repair
New data from a landmark clinical trial found that after five years, transcatheter aortic valve replacement (TAVR) demonstrated a persistent mortality benefit...
3-d pronting, 3D printing
The FDA has recognized 3-D printing technology now exists to print medical devices and is gathering information regarding technical assessments that should be...
May 2, 2014 — Medtronic Inc. revealed new data demonstrating positive outcomes for extreme risk patients with severe aortic stenosis who were treated with the...
Evena Eyes-On Glasses Cath Lab Hybrid OR Vascular Access
Evena Medical’s Eyes-On Glasses is a sophisticated wearable computing platform for vascular imaging and informatics convergence. Its multi-
IMRIS Inc.’s upgraded Visius Surgical Theatre integrates Siemens' high-field MR scanners. The core imaging technology based on Siemens Aera...
Medtronic’s self-expanding transcatheter aortic valve replacement (TAVR) CoreValve System is the first self-expanding TAVR valve...
The Ziehm Vision RFD Hybrid Edition C-arm is tailored to hybrid OR requirements. It is fully motorized in four axes and features an...

Articles

U.S. CoreValve High Risk trial TCT 2014
According to a new study, transcatheter aortic valve replacement (TAVR) provided meaningful clinical benefits relative to surgical aortic valve replacement (...
Mr. KH is a 58-year-old male with a past medical history of hypertension and tobacco abuse who presented to the  emergency department (ED) with an episode...
3-d pronting, 3D printing
The FDA has recognized 3-D printing technology now exists to print medical devices and is gathering information regarding technical assessments that should be...
May 2, 2014 — Medtronic Inc. revealed new data demonstrating positive outcomes for extreme risk patients with severe aortic stenosis who were treated with the...

Video Center

By Dave Fornell, editor of DAIC Magazine The key take away messages from the 26th annual...
3 days 18 hours ago
As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
3 weeks 5 days ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
9 weeks 3 days ago
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
This webinar demonstrates the Centricity Cardio Enterprise Solution (CCE), a solution that can help cardiology departments and hospital administrators to...